Company Contact: TSO, Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: info@tso3.com; Investor Relations: Liolios Group, Inc., Chris Tyson, Tel: 949 574-3860, TOS@liolios.com; Renmark Financial Communications Inc., Barry Mire, Tel: 416 644-2020 or 514 939-3989, bmire@renmakfinancial.comCopyright CNW Group 2015
TSO3 Appoints Glen Kayll as Chief Financial Officer
View original source (CNW)TSO3 Inc on 6ix
Earlier from TSO3
- TSO3 Establishes Medical Industry's First-Ever Claims for Duodenoscope Terminal Sterilization
- TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution Agreement
- TSO3 Appoints Steve West to Board of Directors
- TSO3 Reports Third Quarter 2015 Financial Results
- TSO3 Allowed Expanded Claims for Revolutionary STERIZONE® VP4 Sterilizer
Later from TSO3
- TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 Sterilizer
- TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device Sterilizer
- TSO3 Accelerates Warrant Expiry Date
- TSO3 Appoints Harold R. Tessman as COO
- TSO3 Announces $13.5 million in Warrant Proceeds
Follow TSO3 into a list and get an email when it puts out news.
Follow TSO3